On a per-share basis, the
The biopharmaceutical company posted revenue of
For the year, the company reported that its loss narrowed to
In the final minutes of trading on Monday, the company's shares hit
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from
Copyright by Automated Insights, Inc. All rights reserved., source